Indaptus Therapeutics (INDP) traded up 5.69 % during a 24 hours period ending at 03:21 PM Central Europe on Monday 26th. One Indaptus Therapeutics stock can currently be bought for about USD 3.27 on popular exchanges. Current supply of Indaptus Therapeutics stocks is 153.6 mn. Indaptus Therapeutics has a current market capitalization of USD 485.3 mn and approximately USD 908.5 k worth of Indaptus Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Indaptus Therapeutics has traded -21 % down. Simple moving average of last 200 days is at USD 2.28. The highest price of past 52 weeks was recorded at USD 5.96 on 06/04/2026. 52 weeks low was at USD 0.92 on 08/18/2026.

Here is how related stocks have performed in the past 24 hours:

  • Southern First Bancshares (SFST) traded down -0.07 % and now trades at USD 62.5. Southern First Bancshares has a market capitalisation of USD 579.7 mn. Southern First Bancshares has a current price to earnings ratio of 12.61.

  • Shenandoah Telecommunication (SHEN) traded up 0.49 % and now trades at USD 10.28. Current market capitalisation for Shenandoah Telecommunication is USD 573 mn.

  • Ironwood (IRWD) traded down -3.08 % and now trades at USD 3.53. Ironwood has a market capitalisation of USD 571.7 mn. Ironwood has a current price to earnings ratio of 4.37.

  • Eve (EVEX) traded flat 0 % and now trades at USD 1.55. Current market capitalisation for Eve is USD 571.5 mn.

  • Anteris Glo (AVR) traded down -2.17 % and now trades at USD 5.83. Current market capitalisation for Anteris Glo is USD 572.3 mn.

About Indaptus Therapeutics

Indaptus Therapeutics, Inc. is a clinical stage biopharmaceutical company based in the United States with its main operations in NEW YORK. The company’s mission is to develop proprietary platforms that harness bacteria’s natural ability to stimulate both innate and adaptive cellular immune pathways. As a health care sector player, Indaptus Therapeutics globaly serves customers with its operations website available at www.indaptusrx.com and listed on the Nasdaq stock exchange.